Table 1. IC50 for Ibrutinib in leukemic B-cell lines.
| Leukemic cells | IC50 Ibrutinib (μM) | |
|---|---|---|
| 24 hours | 48 hours | |
| EHEB | 18 | 11.5 |
| JVM-2 | 14.8 | 5.4 |
| JVM-3 | 19 | 14.8 |
| MEC-1 | 18.6 | 10 |
| MEC-2 | 15.3 | 10 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.